The University of North Carolina at Chapel Hill — Chapel Hill, North Carolina

Public research footprint of The University of North Carolina at Chapel Hill, compiled from the ClinicalTrials.gov public registry.

177

Registered studies

Active

Recruiting now

102

Completed

Stopped or withdrawn

Most-studied conditions

Neoplasms · Suspected KITD816V Mutated Clonal Mast Cell Disease · Carcinoma, Non-Small-Cell Lung · Adult T-Cell Leukemia/Lymphoma

Recently updated registry entries

NCT04919122 — Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell… (Active Not Recruiting)
NCT04958239 — A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With… (Active Not Recruiting)
NCT06447168 — A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The University of North Carolina at Chapel Hill?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.